← Back to Analyst Consensus 
SNSE Buy
Sensei Biotherapeutics, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 22, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| Jun 15, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 11, 2026 | BTIG | initiate | — → Buy | — | 52% |
| May 29, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| May 28, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 34% |
| May 22, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Oct 30, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Aug 5, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Mar 28, 2025 | Oppenheimer | maintain | Outperform → Outperform | $4 | 52% |
| Mar 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Jan 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Aug 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| May 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| May 24, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $5 | 54% |
| May 14, 2024 | Stephens & Co. | initiate | — → Overweight | $5 | 54% |
| Dec 4, 2023 | HC Wainwright & Co. | initiate | — → Buy | $4 | 44% |
| Dec 13, 2022 | Citigroup | initiate | — → Buy | $6 | 54% |
| Oct 3, 2022 | Oppenheimer | upgrade | Perform → Outperform | $5 | 52% |
| Mar 10, 2022 | Piper Sandler | maintain | — → Overweight | $10 | 54% |
| Jul 1, 2021 | Berenberg | downgrade | Buy → Hold | $12 | 29% |
| Jun 29, 2021 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Mar 1, 2021 | Oppenheimer | initiate | — → Outperform | $36 | 52% |
| Mar 1, 2021 | Piper Sandler | initiate | — → Overweight | $25 | 54% |
Price Target Trend
Apr 23, 2026 Latest: $51.67 Aug 14, 2026
EPS Estimates
+1q $-6.98
Lo: $-10.44 Hi: $-1.00
3 analysts 0y $-132.38
Lo: $-161.01 Hi: $-101.68
3 analysts 0q $-6.42
Lo: $-10.07 Hi: $-0.98
3 analysts +1y $-9.21
Lo: $-13.86 Hi: $-4.13
3 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days